Kara Lea Vine (Kara L Vine)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 24

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

PLoS computational biology

International journal of molecular sciences

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Cuthbertson, Amy Button, Chloe Sligar, Amal Elhage, Kara Lea Vine, Debbie Watson, Ronald Sluyter
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice. International journal of molecular sciences 25 (3) (2024)
Peter Cuthbertson, Amy Button, Chloe Sligar, Amal Elhage, Kara Lea Vine, Debbie Watson, Ronald Sluyter
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice. International journal of molecular sciences 25 (3) (2024)
Peter Cuthbertson, Amy Button, Chloe Sligar, Amal Elhage, Kara Lea Vine, Debbie Watson, Ronald Sluyter
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice. International journal of molecular sciences 25 (3) (2024)
Chloe Sligar, Ellie Reilly, Peter Cuthbertson, Kara Lea Vine, Katrina M Bird, Amal Elhage, Stephen I Alexander, Ronald Sluyter, Debbie Watson
Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice. Clinical & translational immunology 13 (3) (2024)
Peter Cuthbertson, Amy Button, Chloe Sligar, Amal Elhage, Kara Lea Vine, Debbie Watson, Ronald Sluyter
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice. International journal of molecular sciences 25 (3) (2024)
Chloe Sligar, Ellie Reilly, Peter Cuthbertson, Kara Lea Vine, Katrina M Bird, Amal Elhage, Stephen I Alexander, Ronald Sluyter, Debbie Watson
Graft-versus-leukaemia immunity is retained following treatment with post-transplant cyclophosphamide alone or combined with tocilizumab in humanised mice. Clinical & translational immunology 13 (3) (2024)
Peter Cuthbertson, Amy Button, Chloe Sligar, Amal Elhage, Kara Lea Vine, Debbie Watson, Ronald Sluyter
Post-Transplant Cyclophosphamide Combined with Brilliant Blue G Reduces Graft-versus-Host Disease without Compromising Graft-versus-Leukaemia Immunity in Humanised Mice. International journal of molecular sciences 25 (3) (2024)
Adrianne L Jenner, Wayne Kelly, Michael Dallaston, Robyn P Araujo, Isobelle Parfitt, Dominic Steinitz, Pantea Pooladvand, Peter S Kim, Samantha J Wade, Kara Lea Vine
Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model. PLoS computational biology 19 (1) (2023)
Adrianne L Jenner, Wayne Kelly, Michael Dallaston, Robyn P Araujo, Isobelle Parfitt, Dominic Steinitz, Pantea Pooladvand, Peter S Kim, Samantha J Wade, Kara Lea Vine
Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model. PLoS computational biology 19 (1) (2023)
Adrianne L Jenner, Wayne Kelly, Michael Dallaston, Robyn P Araujo, Isobelle Parfitt, Dominic Steinitz, Pantea Pooladvand, Peter S Kim, Samantha J Wade, Kara Lea Vine
Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model. PLoS computational biology 19 (1) (2023)
Adrianne L Jenner, Wayne Kelly, Michael Dallaston, Robyn P Araujo, Isobelle Parfitt, Dominic Steinitz, Pantea Pooladvand, Peter S Kim, Samantha J Wade, Kara Lea Vine
Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model. PLoS computational biology 19 (1) (2023)
Orlagh M Feeney, Christopher J H Porter, Kara Lea Vine
Introducing the Molecular Pharmaceutics Special Issue on "Emerging Trends in Molecular Pharmaceutics across Australasia". Molecular pharmaceutics 20 (4) (2023)
Ashna A Kumar, Kara Lea Vine, Marie Ranson
Recent Advances in Targeting the Urokinase Plasminogen Activator with Nanotherapeutics. Molecular pharmaceutics (2023)
Adrianne L Jenner, Wayne Kelly, Michael Dallaston, Robyn P Araujo, Isobelle Parfitt, Dominic Steinitz, Pantea Pooladvand, Peter S Kim, Samantha J Wade, Kara Lea Vine
Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model. PLoS computational biology 19 (1) (2023)
Gary Tincknell, Asma Naveed, Jane Nankervis, Ayesha Mukhtiar, Ann-Katrin Piper, Therese Maria Becker, Lorraine Chantrill, Morteza Aghmesheh, Kara Lea Vine, Marie Ranson, Daniel Brungs
HER2-Positive Gastroesophageal Cancers Are Associated with a Higher Risk of Brain Metastasis. Cancers 14 (23) (2022)
Gary Tincknell, Asma Naveed, Jane Nankervis, Ayesha Mukhtiar, Ann-Katrin Piper, Therese Maria Becker, Lorraine Chantrill, Morteza Aghmesheh, Kara Lea Vine, Marie Ranson, Daniel Brungs
HER2-Positive Gastroesophageal Cancers Are Associated with a Higher Risk of Brain Metastasis. Cancers 14 (23) (2022)
Gary Tincknell, Asma Naveed, Jane Nankervis, Ayesha Mukhtiar, Ann-Katrin Piper, Therese Maria Becker, Lorraine Chantrill, Morteza Aghmesheh, Kara Lea Vine, Marie Ranson, Daniel Brungs
HER2-Positive Gastroesophageal Cancers Are Associated with a Higher Risk of Brain Metastasis. Cancers 14 (23) (2022)
Gary Tincknell, Ann-Katrin Piper, Morteza Aghmesheh, Therese Maria Becker, Kara Lea Vine, Daniel Brungs, Marie Ranson
Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma. Cancers 13 (16) (2021)
Sepehr Talebian, In Kyong Shim, Javad Foroughi, Gorka Orive, Kara Lea Vine, Song-Cheol Kim, Gordon George Wallace
3D-Printed Coaxial Hydrogel Patches with Mussel-Inspired Elements for Prolonged Release of Gemcitabine. Polymers 13 (24) (2021)
Gayathri R Ediriweera, Liyu Chen, Justin J Yerbury, Kristofer J Thurecht, Kara Lea Vine
Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives. Molecular pharmaceutics 18 (6) (2021)
Lisa Belfiore, Darren N Saunders, Marie Ranson, Kara Lea Vine
N-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer. Pharmaceutics 12 (7) (2020)
Bryce Keenan, Rocio K Finol-Urdaneta, Ashleigh Hope, John B Bremner, Maria Kavallaris, Daniel Lucena-Agell, María Ángela Oliva, Jose Fernando Díaz, Kara Lea Vine
N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity. Cancer cell international 20 (2020)
Samantha J Wade, Zeliha Sahin, Ann-Katrin Piper, Sepehr Talebian, Morteza Aghmesheh, Javad Foroughi, Gordon G Wallace, Simon E Moulton, Kara Lea Vine
Dual Delivery of Gemcitabine and Paclitaxel by Wet-Spun Coaxial Fibers Induces Pancreatic Ductal Adenocarcinoma Cell Death, Reduces Tumor Volume, and Sensitizes Cells to Radiation. Advanced healthcare materials 9 (21) (2020)
Ronald Sluyter, Kara Lea Vine
N-Alkyl-Substituted Isatins Enhance P2X7 Receptor-Induced Interleukin-1β Release from Murine Macrophages. Mediators of inflammation 2016 (2016)